The loss of Moderna under GAAP for 6 months of 2020 amounted to $240,943 million, which is 9.9% lower compared to $267,516 million in the previous year. Revenue increased by 2.5 times to $74.74 million compared to $29.108 million a year earlier.
The loss of Moderna under GAAP for 6 months of 2020 amounted to $240,943 million, which is 9.9% lower compared to $267,516 million in the previous year. Revenue increased by 2.5 times to $74.74 million compared to $29.108 million a year earlier. 
investors.modernatx.com
English (US) 